Chemoinformaics analysis of TRITRIACONTAN-3-ONE
| Molecular Weight | 478.89 | nRot | 30 |
| Heavy Atom Molecular Weight | 412.362 | nRig | 49 |
| Exact Molecular Weight | 478.511 | nRing | 0 |
| Solubility: LogS | -4.556 | nHRing | 0 |
| Solubility: LogP | 4.476 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 100 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 66 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 33 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 99.9203 |
| nHD | 0 | BPOL | 67.0797 |
| QED | 0.144 |
| Synth | 7.21 |
| Natural Product Likeliness | 1.587 |
| NR-PPAR-gamma | 0.104 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.334 |
| Pgp-sub | 0.971 |
| HIA | 0.958 |
| CACO-2 | -5.29 |
| MDCK | 0.0000155 |
| BBB | 0.232 |
| PPB | 0.82699 |
| VDSS | 1.558 |
| FU | 0.122237 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.983 |
| CYP2c19-inh | 0.054 |
| CYP2c19-sub | 0.937 |
| CYP2c9-inh | 0.113 |
| CYP2c9-sub | 0.358 |
| CYP2d6-inh | 0.946 |
| CYP2d6-sub | 0.862 |
| CYP3a4-inh | 0.928 |
| CYP3a4-sub | 0.937 |
| CL | 2.635 |
| T12 | 0.001 |
| hERG | 0.798 |
| Ames | 0.062 |
| ROA | 0.996 |
| SkinSen | 0.008 |
| Carcinogencity | 0.779 |
| EI | 0.005 |
| Respiratory | 0.965 |
| NR-Aromatase | 0.213 |
| Antiviral | No |
| Prediction | 0.608087 |